Css LLC Apellis Pharmaceuticals, Inc. Transaction History
Css LLC
- $999 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$510 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$389 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$364 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$321 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$190 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.6B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...